See 1.x and Figure 1.1

Suggest documenting the Guideline Development Life Cycle to (e.g. from Evidence to Narrative to CPG to local Health Care Org "Pathway") to differentiate key terms and separation of concerns. Perhaps some domain model from a group such as the CDC sponsored "Adapting Clinical Guidelines to the Digital Age" WG could contribute?

What is the Lifecyle and provenance of Evidence (see EBM workgroup efforts) and Recommendations?

What should be address by Guideline Developers versus local HCO's (e.g. decision criteria, parameters, and setting-specific factors including workflow and specific CDS behaviors)?